Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Microbot Medical Inc (NASDAQ:MBOT)

5.10
Delayed Data
As of Apr 28
 -0.01 / -0.20%
Today’s Change
2.97
Today|||52-Week Range
39.90
-16.39%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$139.0M

Company Description

Microbot Medical, Inc. engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. Its carries out its operations through the ViRob and TipCat paltforms. The company's ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt (SCS), a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid (CSF) shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCAT platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. It is developed for use in colonoscopy procedures. The company was founded by Harel Gadot, Moshe Shoham, and Yossi Bornstein in 2010, and is headquartered in Hingham, MA.

Contact Information

Microbot Medical, Inc.
175 Derby Street, 27/1
Hingham Massachusetts 02043
P:(908) 938-5561
Investor Relations:

Employees

Shareholders

Mutual fund holders0.32%
Other institutional0.23%
Individual stakeholders--

Top Executives

Harel GadotChairman, President & Chief Executive Officer
Yehezkel HimelfarbChief Operating Officer & General Manager
David Ben NaimChief Financial Officer
Eyal Ben-MosheVice President-Research & Development
Ahava SteinVice President-Regulatory Affairs & QA